Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLuzerner Kantonsspital
About this trial
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ICD-10 Diagnosis of stroke, TBI or MS
Admitted to the inpatient and/or outpatient in the Clinic for Neurology and Neurorehabilitation
Age 18 years old or older
Understanding the German language
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Intervention Hypnosis
Other interventionHypnosis sessions designed to improve attentional control and reduce fatigue in patients with neurological conditions (stroke, TBI, MS). The intervention involves guided hypnotic induction and suggestions tailored to enhance cognitive focus and energy management.
Treatment groups
48 Participants
are divided into 2 treatment groupsGroup A: active: Intervention HypnosisExperimental treatment 1 intervention
Group B: Placebo: Control Sham HypnosisSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility of the study design and procedures
The primary objective is to evaluate the feasiblity of conducting the study by assessing the completion rate.
Time frame
From enrollment to the end of treatment at 3 weeksSecondary outcomes
1
Video-oculography during free visual exploration
The secondary endpoint is change in eye movement parameters during free visual exploration (FVE) from pre- to post-intervention, measured by video-oculography (mean gaze positions measured in °). Furthermore, between-group differences (hypnosis vs sham-hypnosis) in FVE parameters post-intervention.
Time frame
Change before and after the intervention over the period of 3 weeks.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov